RxDoctor Payments Data

Jaimee Larson, PA

Physician Assistant · Green Bay, WINPI 1225419120

Payments from drug & device makers

$543in general payments, 2019–2025

Across 21 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BETA Bionics, Inc.$207
  • Medtronic$151
  • Insulet Corporation$46
  • GSK$32
  • Zealand Pharma US, Inc.$25
  • Antares Pharma, Inc.$24
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$52997%
  • Education$143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$543 in reported general payments places this provider in the 80th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$12,499
Medicare patients
72
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide135$205,956
Soliqua 100-33Insulin Glargine/Lixisenatide92$138,468
JardianceEmpagliflozin97$130,658
Tresiba Flextouch U-200Insulin Degludec45$129,959
MounjaroTirzepatide80$107,310
TrulicityDulaglutide91$101,286
Humulin R U-500 KwikpenInsulin Regular, Human25$82,561
Humalog Kwikpen U-200Insulin Lispro14$56,219
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog33$53,563
Lantus SolostarInsulin Glargine,hum.Rec.Anlog195$48,877
Xultophy 100-3.6Insulin Degludec/Liraglutide14$35,158
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog33$30,930
Novolog FlexpenInsulin Aspart59$29,331
Humalog Kwikpen U-100Insulin Lispro57$29,012
Tresiba Flextouch U-100Insulin Degludec39$28,805

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$14$223,832224 claims
IBSA Pharma Inc.Tirosint$19$6,87419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in Green Bay

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →